C4 Therapeutics vs Voyager Therapeutics
C4 Therapeutics and Voyager Therapeutics are similar in size: $35.9m and $40.4m of revenue in their latest fiscal years. C4 Therapeutics grew faster (1.0% against -49.5%). C4 Therapeutics kept more of each dollar of sales as profit: a net margin of -292.1% against -296.5%. C4 Therapeutics carries less debt relative to equity (0.0% against 0.0%).
| Latest fiscal year | C4 TherapeuticsCCCC, 2025 | Voyager TherapeuticsVYGR, 2025 |
|---|---|---|
| Revenue | $35.9m | $40.4m |
| Revenue growth | 1.0% | -49.5% |
| Net income | −$105m | −$120m |
| Operating margin | -320.5% | -326.6% |
| Net margin | -292.1% | -296.5% |
| Return on equity | -44.4% | -48.3% |
| Free cash flow | −$99.3m | −$135m |
| Cash | $74.6m | $65.3m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $193,000 | — |
| Employees | 104 | 141 |
| Market value | $395m | $109m |
| Price vs our value range | — | — |
| Moat score | 12 (Weak) | 11 (Weak) |
| Insider trades, 12 months | 0 buys, 1 sales | 0 buys, 11 sales |